Article
High- and low-penetrance cutaneous melanoma susceptibility genes.
Expert review of anticancer therapy - 1 May 2006
Fargnoli Maria Concetta, Argenziano Giuseppe, Zalaudek Iris, Peris Ketty
Abstract excerpt
The aim of this review is to report the current understanding of the molecular genetics of melanoma predisposition. To date, two high-penetrance melanoma susceptibility genes, cyclin-dependent kinas inhibitor (CDKN)2A on chromosome 9p21 and cyclin-dependent kinase (CDK4) on 12q13, have been identified. Germline inactivating mutations of the CDKN2A gene are the most common cause of inherited susceptibility to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
